APA (7th ed.) Citation

Fell, M. J., Svensson, K. A., Johnson, B. G., & Schoepp, D. D. (2008). Evidence for the Role of Metabotropic Glutamate (mGlu)2 Not mGlu3 Receptors in the Preclinical Antipsychotic Pharmacology of the mGlu2/3 Receptor Agonist (–)-(1 R, 4 S,5 S,6 S)-4-Amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic Acid (LY404039). The Journal of pharmacology and experimental therapeutics, 326(1), 209-217. https://doi.org/10.1124/jpet.108.136861

Chicago Style (17th ed.) Citation

Fell, Matthew J., Kjell A. Svensson, Bryan G. Johnson, and Darryle D. Schoepp. "Evidence for the Role of Metabotropic Glutamate (mGlu)2 Not MGlu3 Receptors in the Preclinical Antipsychotic Pharmacology of the MGlu2/3 Receptor Agonist (–)-(1 R, 4 S,5 S,6 S)-4-Amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic Acid (LY404039)." The Journal of Pharmacology and Experimental Therapeutics 326, no. 1 (2008): 209-217. https://doi.org/10.1124/jpet.108.136861.

MLA (9th ed.) Citation

Fell, Matthew J., et al. "Evidence for the Role of Metabotropic Glutamate (mGlu)2 Not MGlu3 Receptors in the Preclinical Antipsychotic Pharmacology of the MGlu2/3 Receptor Agonist (–)-(1 R, 4 S,5 S,6 S)-4-Amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic Acid (LY404039)." The Journal of Pharmacology and Experimental Therapeutics, vol. 326, no. 1, 2008, pp. 209-217, https://doi.org/10.1124/jpet.108.136861.